drugset / Trial / NCT02341482
A Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics of PF-04958242 in Healthy Subjects
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of the current study is to characterize the pharmacokinetic (PK) profile of PF 04958242 when co administered with a strong cytochrome P450 3A4 (CYP3A4) inhibitor.
Timeline
- Start
- 2015-02-05
- Primary completion
- 2015-03-31
- Completion
- 2015-03-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PESAMPATOR | Small molecule | 0.025 mg | — |
| Background | Itraconazole | Small molecule | 200 mg | — |
Indications
No indication recorded.